Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Sanofi, BEYFORTUS
Sanofi begins shipping BEYFORTUS to US for RSV prevention in infants
French multinational pharmaceutical company Sanofi has commenced the shipping of BEYFORTUS (nirsevimab-alip) to the US, targeting both private healthcare providers and the Centers for Disease Control and Prevention's Vaccines for Children programme,
Sanofi To Offer BEYFORTUS Doses To Protect Babies During RSV Season - Quick Facts
Sanofi (SNYNF, SNY) said it is shipping BEYFORTUS 50mg and 100mg Injection doses in the US to private healthcare providers and to the
Sanofi, AstraZeneca win US approval for RSV therapy manufacturing line
Sanofi and partner AstraZeneca have received approval from the U.S. Food and Drug Administration for a manufacturing line for their preventive respiratory syncytial virus (RSV) therapy, the French drugmaker said on Monday.
Sanofi Shipping BEYFORTUS® In US To Help Protect Babies Against RSV Disease New Manufacturing Line Approved By FDA
Company planning for every eligible baby in the US to have access to BEYFORTUS <li /> New BEYFORTUS filling line approved by the
Sanofi begins shipping BEYFORTUS to US for RSV prevention in infants
French multinational pharmaceutical company Sanofi has commenced the shipping of
BEYFORTUS
(nirsevimab-alip) to the US, targeting both private healthcare providers and the Centers for Disease ...
US FDA approves manufacturing line for Sanofi's preventive RSV therapy
Sanofi said on Monday the U.S. Food and Drug Administration has approved a manufacturing line for its and partner AstraZeneca's preventive respiratory syncytial virus (RSV) therapy.
FiercePharma
4d
With amped up manufacturing effort, Sanofi and AZ look to avoid Beyfortus shortfalls this year
As this year’s respiratory syncytial virus (RSV) season approaches,
Beyfortus
makers Sanofi and AstraZeneca are making ...
TBR News Media
1d
Local doctors recommend flu and covid shots cosome time in the next few weeks
With the peak flu season often occurring during December and January and even into February, Dr. Sharon Nachman, Chief of the ...
3d
RSV Can Be a Killer. New Tools Are Identifying the Most At-Risk Kids
RSV infects almost every child before they turn 2, and kills more than 100,000 infants worldwide each year. Machine learning ...
1d
After years of advocacy by a pediatrician, all Nunavut babies to get RSV immunization
The Nunavut government says it will provide immunization against respiratory syncytial virus to all infants in the territory ...
Jefferson Public Radio
1d
COVID-19, RSV, flu: Updated shots are available now in Oregon
October: time for muddy soccer practices, cider pressing and Halloweentown ... And time to roll up your sleeves.
2d
Sanofi: A Strong Buy on Earnings Growth, Pipeline Progress, and Market Catalysts
Analyst Graham Parry of Bank of America Securities maintained a Buy rating on Sanofi (SNYNF – Research Report), retaining the price ...
BioPharma Dive
5d
Sanofi readies to meet US demand for RSV antibody
With a new production line, Sanofi aims to keep it and partner AstraZeneca’s drug Beyfortus in fully supply this RSV season.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Sanofi
RSV
United States
Feedback